Literature DB >> 8046676

Tetanus in the horse: a review of 20 cases (1970 to 1990).

S L Green1, C B Little, J D Baird, R R Tremblay, L L Smith-Maxie.   

Abstract

The case records of 20 horses with tetanus referred to the Ontario Veterinary College-Veterinary Teaching Hospital between 1970 and 1990 were reviewed. The fatality rate was 75%. There was a strong association with previous vaccination and survival (P = .03). Most of the animals had been injured an average of 9 days (range 2 to 21 days) prior to development of clinical signs. Hyperesthesia and prolapse of the third eyelid were the most common clinical signs. Treatment regimens varied during hospitalization; however, all horses received parenteral penicillin, tranquilizers, tetanus toxoid, and antitoxin. Five of the nonsurviving animals were given intrathecal tetanus antitoxin. One animal had seizures as a complication of intrathecal treatment. The prognosis was best for horses that (1) had been vaccinated prior to the injury, (2) responded to the phenothiazine tranquilizers, and (3) did not rapidly (over 24 to 48 hours) become recumbent. Considering the species susceptibility, potential for contaminated wounds, and the increased survival of vaccinated horses, yearly revaccination is recommended.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046676     DOI: 10.1111/j.1939-1676.1994.tb03210.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  4 in total

1.  Clinical findings and response to treatment of 17 cases of tetanus in horses (2012-2021).

Authors:  Ubiratan Pereira de Melo; Cintia Ferreira
Journal:  Rev Bras Med Vet       Date:  2022-03-23

Review 2.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

Review 3.  Clostridial Diseases of Horses: A Review.

Authors:  Francisco A Uzal; Mauricio A Navarro; Javier Asin; Eileen E Henderson
Journal:  Vaccines (Basel)       Date:  2022-02-17

Review 4.  Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.

Authors:  Hélène Desanti-Consoli; Juliette Bouillon; Ronan J J Chapuis
Journal:  Vaccines (Basel)       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.